| Novel ALK fusion partners in lung cancer AG Iyevleva, GA Raskin, VI Tiurin, AP Sokolenko, NV Mitiushkina, ... Cancer letters 362 (1), 116-121, 2015 | 101 | 2015 |
| Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers AP Sokolenko, EL Savonevich, AO Ivantsov, GA Raskin, ES Kuligina, ... Cancer letters 397, 127-132, 2017 | 53 | 2017 |
| Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients AP Sokolenko, EV Preobrazhenskaya, SN Aleksakhina, AG Iyevleva, ... Cancer letters 359 (2), 259-261, 2015 | 42 | 2015 |
| Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors EV Preobrazhenskaya, AG Iyevleva, AM Suleymanova, VI Tiurin, ... Pediatric Blood & Cancer 67 (5), e28220, 2020 | 35 | 2020 |
| Detection of ALK rearrangements in 4002 Russian patients: The utility of different diagnostic approaches I Demidova, V Grinevich, A Avdalian, E Imyanitov, M Gikalo, N Savelov, ... Lung Cancer 103, 17-23, 2017 | 24 | 2017 |
| Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment AG Iyevleva, NV Mitiushkina, NA Karaseva, SV Orlov, LN Volodina, ... Journal of Thoracic Oncology 9 (4), e31-e33, 2014 | 23 | 2014 |
| EGFR T790M mutation in TKI-naïve clinical samples: frequency, tissue mosaicism, predictive value and awareness on artifacts ED Lavdovskaia, AG Iyevleva, AP Sokolenko, NV Mitiushkina, ... Oncology research and treatment 41 (10), 634-642, 2018 | 19 | 2018 |
| Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants NV Mitiushkina, VI Tiurin, AG Iyevleva, MM Kholmatov, EA Filippova, ... Biochimie 154, 19-24, 2018 | 18 | 2018 |
| Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study SV Orlov, AG Iyevleva, EA Filippova, AM Lozhkina, SV Odintsova, ... Translational Oncology 14 (8), 101121, 2021 | 14 | 2021 |
| Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping NV Mitiushkina, MM Kholmatov, VI Tiurin, AA Romanko, OS Yatsuk, ... Biochimie 165, 267-274, 2019 | 14 | 2019 |
| KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas AS Martianov, NV Mitiushkina, AN Ershova, DE Martynenko, MG Bubnov, ... International Journal of Molecular Sciences 24 (5), 4868, 2023 | 13 | 2023 |
| PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience. NV Mitiushkina, MM Kholmatov, AR Venina, VI Tiurin, GA Yanus, ... Neoplasma 65 (6), 972-979, 2018 | 12 | 2018 |
| Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer NV Mitiushkina, AA Romanko, EV Preobrazhenskaya, VI Tiurin, ... Cancer Medicine 11 (17), 3226-3237, 2022 | 11 | 2022 |
| ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers RS Mulkidjan, ES Saitova, EV Preobrazhenskaya, KA Asadulaeva, ... International Journal of Molecular Sciences 24 (17), 13610, 2023 | 9 | 2023 |
| Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas VI Tiurin, EV Preobrazhenskaya, NV Mitiushkina, AA Romanko, ... International Journal of Molecular Sciences 24 (13), 10530, 2023 | 7 | 2023 |
| Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples AA Romanko, RS Mulkidjan, VI Tiurin, ES Saitova, EV Preobrazhenskaya, ... International Journal of Molecular Sciences 24 (18), 14203, 2023 | 6 | 2023 |
| Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel NV Mitiushkina, VI Tiurin, AA Anuskina, NA Bordovskaya, AD Shestakova, ... Diagnostics 13 (20), 3168, 2023 | 3 | 2023 |
| Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine TN Sokolova, VV Breder, IS Shumskaya, EN Suspitsin, SN Aleksakhina, ... Hereditary Cancer in Clinical Practice 19, 1-7, 2021 | 3 | 2021 |
| Pathways and targeting avenues of BRAF in non-small cell lung cancer EN Imyanitov, NV Mitiushkina, ES Kuligina, VI Tiurin, AR Venina Expert Opinion on Therapeutic Targets 28 (7), 613-622, 2024 | 1 | 2024 |
| Lung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors EN Imyanitov, NV Mitiushkina, VI Tiurin, AG Iyevleva, M Holmatov, ... Annals of Oncology 29, viii502, 2018 | 1 | 2018 |